Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 242
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT06828042 Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refrac… |
anti-CD19 CAR T cell therapy | SEP | Phase 1/2 | RECRUITING | En attente / non publié | Peking University Third Hospital | China · Peking University Third Hospital, Beijing, Ch… | 2025-07-01 → 2027-12-31 | Ouvrir |
| NCT07782450 A Study to Learn About a Medicine Called PF-08154225 in Participants Wi… |
PF-08154225 | Myopathies | Phase 1/2 | NOT_YET_RECRUITING | En attente / non publié | Pfizer | Non communiqué | 2026-11-19 → 2031-02-22 | Ouvrir |
| NCT07844200 Bela-SLE — The Primary Objective of the Trial is to Evaluate the Effect… |
belantamab mafodotin to the exist… | Lupus | Phase 2 | NOT_YET_RECRUITING | En attente / non publié | Medical Association for the Study… | Non communiqué | 2027-02 → 2031-12 | Ouvrir |
| NCT07038447 A Study of KITE-363 in Participants With Refractory Autoimmune Diseases |
KITE-363 | Lupus | Phase 1 | ENROLLING_BY_INVITATION | En attente / non publié | Kite, A Gilead Company | United States, Australia, Canada, South Korea · ASAN … | 2025-07-02 → 2030-09 | Ouvrir |
| NCT05411016 A Study of KK4277 in Healthy Volunteers and Patients With Systemic Lupu… |
KK4277 | Lupus | Phase 1 | COMPLETED | En attente / non publié | Kyowa Kirin Co., Ltd. | Japan, South Korea · Ajou University Hospital, Suwon,… | 2022-08-03 → 2025-10-27 | Ouvrir |
| NCT04643067 Lupus — Phase 1b/2a Study to Evaluate Safety and Efficacy of KPG-818 in… |
KPG-818 low dose in phase 1b | Lupus | Phase 1/2 | COMPLETED | En attente / non publié | Kangpu Biopharmaceuticals, Ltd. | United States · Accurate Clinical Management, Houston… | 2021-06-03 → 2023-06-29 | Ouvrir |
| NCT07299422 A Study of SHR-2173 in Participants With Systemic Lupus Erythematosus |
SHR-2173 injection | Lupus | Phase 2 | RECRUITING | En attente / non publié | Guangdong Hengrui Pharmaceutical … | China · Chinese Academy of Medical Sciences, Peking U… | 2026-04-03 → 2028-11 | Ouvrir |
| NCT07083349 NK510 Cell Therapy for Refractory Systemic Lupus Erythematosus |
NK510 : allogeneic genetic modifi… | Lupus | Phase 1 | TERMINATED | En attente / non publié | Base Therapeutics (Shanghai) Co.,… | China · The First Affiliated Hospital of Anhui Medica… | 2025-12-01 → 2026-04-01 | Ouvrir |
| NCT07799116 CART-NEL — Study to Evaluate the Safety and Preliminary Efficacy of CD1… |
TranspoCART19 | Lupus | Phase 1/2 | RECRUITING | En attente / non publié | Instituto de Investigación Sanita… | Spain · Clinica Universidad de Navarra, Pamplona, Spa… | 2026-09-23 → 2030-09 | Ouvrir |
| NCT07855302 CD19 CAR-T Therapy for Refractory Childhood-Onset Systemic Lupus Erythe… |
SNUH-CD19-CAR-T Cells | Lupus | Phase 1 | RECRUITING | En attente / non publié | Seoul National University Hospital | South Korea · Seoul National University Hospital, Seo… | 2026-09-14 → 2028-12 | Ouvrir |
| NCT06133972 SIRIUS-SLE LTE — Phase 3 Extension Study to Evaluate Long-term Safety o… |
Ianalumab | Lupus | Phase 3 | RECRUITING | En attente / non publié | Novartis Pharmaceuticals | United States, Argentina, Australia, Brazil, Bulgaria… | 2024-05-21 → 2034-10-02 | Ouvrir |
| NCT04976322 A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol … |
Dapirolizumab pegol | Lupus | Phase 3 | ENROLLING_BY_INVITATION | En attente / non publié | UCB Biopharma SRL | United States, Argentina, Belgium, Bulgaria, Canada, … | 2021-07-27 → 2030-08-07 | Ouvrir |
| NCT07837986 SAFRAN — Investigation of Type I Interferon Excess in Patients With Sys… |
biological samples | Myopathies | Non applicable | NOT_YET_RECRUITING | En attente / non publié | Hospices Civils de Lyon | France · Centre Hospitalier Lyon-Sud, Oullins, France… | 2026-12-01 → 2033-01-01 | Ouvrir |
| NCT07829614 F182112 Phase Ib Clinical Study for the Treatment of Patients With Syst… |
F182112 | Lupus | Phase 1 | RECRUITING | En attente / non publié | Shandong New Time Pharmaceutical … | China · Renji Hospital, Shanghai Jiao Tong University… | 2025-10-30 → 2027-12-31 | Ouvrir |
| NCT07630714 A Study to Investigate Pharmacokinetics, Pharmacodynamics, and Safety o… |
Anifrolumab + APFS | Lupus | Phase 2 | RECRUITING | En attente / non publié | AstraZeneca | Australia, Belgium, Chile, Israel, Japan, Netherlands… | 2026-08-31 → 2031-09-05 | Ouvrir |
| NCT07301164 Clinical Study of BCT301 Cell Injection Therapy for Refractory Autoimmu… |
BCT301 | Lupus | Phase 1 | RECRUITING | En attente / non publié | Peking University Third Hospital | China · Peking University Third Hospital, Beijing, Ch… | 2025-12-11 → 2028-12-31 | Ouvrir |
| NCT06839976 CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for… |
CART19 | Lupus | Phase 1/2 | RECRUITING | En attente / non publié | Children's Hospital of Philadelph… | United States · Children's Hospital of Philadelphia, … | 2025-05-06 → 2030-02-28 | Ouvrir |
| NCT03816345 Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Canc… |
Biospecimen Collection | Lupus | Phase 1 | RECRUITING | En attente / non publié | Roswell Park Cancer Institute | United States, Canada · Dana-Farber Cancer Institute,… | 2019-07-16 → 2028-03-30 | Ouvrir |
| NCT07751848 LOTUS — A Study of Outcomes in Chinese Patients Treated With Anifroluma… |
Anifrolumab | Lupus | Phase 3 | RECRUITING | En attente / non publié | University of Cambridge | China · Research Site, Beijing, China | Research Site… | 2026-08-31 → 2028-08-30 | Ouvrir |
| NCT07840287 A Long-Term Extension (LTE) Study Of Enpatoran In Cutaneous Manifestati… |
Enpatoran | Lupus | Phase 3 | NOT_YET_RECRUITING | En attente / non publié | EMD Serono Research & Development… | United States, Germany · Research Site, Billerica, Un… | 2026-10-15 → 2031-09-01 | Ouvrir |
| NCT05201469 VIBRANT: VIB4920 for Active Lupus Nephritis |
VIB4920 | Lupus | Phase 2 | RECRUITING | En attente / non publié | National Institute of Allergy and… | United States · Columbia University Medical Center: D… | 2022-12-15 → 2028-12 | Ouvrir |
| NCT07823478 HEALTH Home Urinalysis Testing |
Home Urine Testing | Lupus | Non applicable | RECRUITING | En attente / non publié | NYU Langone Health | United States · NYU Langone Health, New York, United … | 2026-09-08 → 2028-09-30 | Ouvrir |
| NCT07823556 The Role of Transforming Growth Factor- Beta (TGF- β) Expression in Ren… |
renal biopsy | Lupus | Non applicable | ACTIVE_NOT_RECRUITING | En attente / non publié | Ain Shams University | Egypt · Ain Shams University, Cairo, Egypt | 2026-05-31 → 2027-09-30 | Ouvrir |
| NCT06916806 TITAN — A Study to Investigate Safety, Tolerability, Pharmacokinetics, … |
AZD5492 | Lupus | Phase 1 | RECRUITING | En attente / non publié | AstraZeneca | United States, Canada, China, France, Germany, Hong K… | 2025-05-01 → 2027-09-15 | Ouvrir |
| NCT05672576 OPUS-2 — A Research Study to Evaluate the Efficacy and Safety of Ceneri… |
Cenerimod | Lupus | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Viatris Innovation GmbH | United States, Chile, Czechia, Georgia, Germany, Indi… | 2023-06-26 → 2027-06-30 | Ouvrir |